To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

Home
About
BIDMC
Centers and
Departments
Patient and Visitor
Information
Quality and
Safety
iHealth
Medical
Education
Research
Give to
BIDMC
left banner
right banner
Smaller Larger
Living With Breast Cancer

  • Easy Chemo

    Posted 3/2/2013 by hhill

      Very honestly, I walk a fine line here. I suspect that most readers (and I hope there are some! Did you see my plea yesterday to please write a comment?) are women who have early breast cancer, but I know that some have advanced/metastatic disease. I am very aware that women with advanced disease too often feel that the breast cancer community ignores them. Once you have moved into that world, it can seem that you are everyone's worst fear, and it is easier to pretend it can't happen.

      This is, therefore, a warning. Today's posting is an excerpt and then a link to the wonderful blog, But, Doctor, I hate pink, written by a woman who has Stage IV breast cancer. This is about so-called "easy" chemo which does seem to be an oxymoron. However, if you have the misfortune to become a chemo expert, to have the varied experiences that might entitle you to write the equivalent of a Zagat guide to breast cancer chemotherapies, you would know that some are much more difficult than others.

    Read more... Comments (0)

  • Kadcyla Approval

    Posted 2/28/2013 by hhill
      This is big news. It is especially important news for women who have her2positive breast cancer. Feeling somewhat like a broken record, let me repeat the reality that much/most research is directed at finding targeted treatments that are effective for specific kinds of cancer cells. The discovery of herceptin changed the whole world of treatment for women with her2 positive breast cancers. What had been a particularly lethal form of the disease became one that was at least as treatable as any other. Many, many women have benefitted from herceptin and have been treated, gone on to stay strong and healthy without a breast cancer recurrence. The FDA announced this week that another drug to treat her2 positive disease, Kadcyla, has been approved. Read more... Comments (0)

Contact Information

Cancer Center
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215
617-667-1900

Categories

Archive

Syndication

Tagcloud

mindfulness meditatiion stress anxiety recurrence fear Supreme Court Myriad Genetics BRCA1 BRCA2 mutations gene testing triple negative chemotherapy targeted therapy

Recent comments

About the Blogger

Hester Hill Schnipper, LICSW, OSW-C is the Manager of Oncology Social Work at BIDMC. For more than thirty years, her daily work at BIDMC has been primarily focused on supporting women with breast cancer. A nationally known writer and speaker, she was the Susan G Komen Breast Cancer Foundation's first Hatcher Survivorship Professor. In 1993, and again in 2005, she was diagnosed with breast cancer and went through the standard treatments of surgery, radiation, chemotherapy, and hormonal therapy. These experiences have given her great credibility with her patients and transformed her life's work to her life. Ms. Schnipper lives gratefully with her husband in an ancient farmhouse outside of Boston and spends as much time as possible in a water front cottage on Mt Desert Island. Between them, they have five adult children and seven grandchildren; she claims biological responsibility for two and three of them.

Connect With Us:
RSS
Facebook
Twitter
YouTube
Read our BIDMC
Read our BIDMC E-LettersE-Letters

© 2013 Beth Israel Deaconess Medical Center
330 Brookline Avenue, Boston, MA 02215
617-667-7000  |  TDD: 800-439-0183  | Maps & Directions